Goods and bads of the endocannabinoid system as a therapeutic target: lessons learned after 30 years

M Maccarrone, V Di Marzo, J Gertsch, U Grether… - Pharmacological …, 2023 - Elsevier
The cannabis derivative marijuana is the most widely used recreational drug in the Western
world and is consumed by an estimated 83 million individuals (∼ 3% of the world …

Endocannabinoid system and exogenous cannabinoids in depression and anxiety: a review

A Hasbi, BK Madras, SR George - Brain sciences, 2023 - mdpi.com
Background: There is a growing liberalization of cannabis-based preparations for medical
and recreational use. In multiple instances, anxiety and depression are cited as either a …

Dual action of ketamine confines addiction liability

LD Simmler, Y Li, LC Hadjas, A Hiver, R Van Zessen… - Nature, 2022 - nature.com
Ketamine is used clinically as an anaesthetic and a fast-acting antidepressant, and
recreationally for its dissociative properties, raising concerns of addiction as a possible side …

Cannabinoids and cytochrome P450 interactions

O Zendulka, G Dovrtelová, K Nosková… - Current drug …, 2016 - ingentaconnect.com
Objective: This review consists of three parts, representing three different possibilities of
interactions between cannabinoid receptor ligands of both exogenous and endogenous …

[HTML][HTML] Endocannabinoid-mediated control of synaptic transmission

M Kano, T Ohno-Shosaku… - Physiological …, 2009 - journals.physiology.org
The discovery of cannabinoid receptors and subsequent identification of their endogenous
ligands (endocannabinoids) in early 1990s have greatly accelerated research on …

The endocannabinoid system as an emerging target of pharmacotherapy

P Pacher, S Bátkai, G Kunos - Pharmacological reviews, 2006 - Elsevier
The recent identification of cannabinoid receptors and their endogenous lipid ligands has
triggered an exponential growth of studies exploring the endocannabinoid system and its …

[LIBRO][B] Distribution of cannabinoid receptors in the central and peripheral nervous system

K Mackie - 2005 - Springer
CB 1 cannabinoid receptors appear to mediate most, if not all of the psychoactive effects of
delta-9-tetrahydrocannabinol and related compounds. This G protein-coupled receptor has …

The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?

RC Pierce, V Kumaresan - Neuroscience & biobehavioral reviews, 2006 - Elsevier
In this review we will critically assess the hypothesis that the reinforcing effect of virtually all
drugs of abuse is primarily dependent on activation of the mesolimbic dopamine system …

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

U Pagotto, G Marsicano, D Cota, B Lutz… - Endocrine …, 2006 - academic.oup.com
During the last few years, the endocannabinoid system has emerged as a highly relevant
topic in the scientific community. Many different regulatory actions have been attributed to …

Obesity: Current and potential pharmacotherapeutics and targets

V Narayanaswami, LP Dwoskin - Pharmacology & therapeutics, 2017 - Elsevier
Obesity is a global epidemic that contributes to a number of health complications including
cardiovascular disease, type 2 diabetes, cancer and neuropsychiatric disorders …